N-Acetyl-L-carnosine

CAS: 56353-15-2

Ref. TR-A172015

Produktinformation

• Name: N-Acetyl-L-carnosine
• Synonyme: (2S)-2-(3-acetamidopropanoylamino)-3-(1H-imidazol-4-yl)propanoic acid, (S)-2-(3-Acetamidopropanamido)-3-(1H-imidazol-4-yl)propanoicacid, <span class="text-smallcaps">L</span>-Histidine, N-(N-acetyl-β-alanyl)-, <span class="text-smallcaps">L</span>-Histidine, N-acetyl-β-alanyl-, Can-C, Histidine, N-(N-acetyl-β-alanyl)-, <span class="text-smallcaps">L</span>-, N-(N-Acetyl-beta-alanyl)-L-histidine, N-(N-Acetyl-β-alanyl)histidine, N-Acetyl Carnosine, N-Acetyl-<span class="text-smallcaps">L</span>-carnosine, N-Acetyl-β-alanyl-<span class="text-smallcaps">L</span>-histidine, N-Acetylcarnosine, N-acetyl-beta-alanyl-L-histidine, N-acetyl-beta-alanylhistidine, Unii-0Tpn86Oqif, N-Acetyl-β-alanyl-L-histidine, L-Histidine, N-acetyl-β-alanyl-, Histidine, N-(N-acetyl-β-alanyl)-, L-, L-Histidine, N-(N-acetyl-β-alanyl)-, Acetylcarnosine

Beschreibung

Applications Used in the treatment of cataracts and in the treatment of UV-induced immunosuppression. May act with with lipoic acid (L468725) to reverse age-related metabolic decline and also the indicies of oxidative stress.
References Babizhayev, M., et al.: J. Pharmacol. Toxicol., 1, 201 (2006), Min, J., et al.: J. Neurosci. Res., 86, 2984 (2008), Babizhayev, M., et al.: J. Drug Target., 17, 36 (2009); Hagen et. al, PNAS 99: 1870 (2002); Liu et. al, PNAS 99, 2356 (2002)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 268.27
• Formel: C₁₁H₁₆N₄O₄
• Farbe/Form: Off-White
• InChl: InChI=1S/C11H16N4O4/c1-7(16)13-3-2-10(17)15-9(11(18)19)4-8-5-12-6-14-8/h5-6,9H,2-4H2,1H3,(H,12,14)(H,13,16)(H,15,17)(H,18,19)/t9-/m0/s1
• InChI Key: InChIKey=BKAYIFDRRZZKNF-VIFPVBQESA-N
• SMILES: CC(=O)NCCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)O